迈向透壁愈合:超声愈合与克罗恩病患者长期结局改善相关
回顾性研究纳入202例临床缓解期克罗恩病患者,基线时61%存在超声炎症。中位随访19个月,超声愈合与药物升级、激素使用风险降低相关,但与住院或手术无显著独立关联。作者认为需进一步研究超声愈合是否应作为治疗目标。
要点
- 临床缓解期克罗恩病患者中,超声愈合与无药物升级生存率升高相关(HR 1.94,95%CI 1.23-3.06)。
- 超声愈合与无激素生存率升高相关(HR 2.41,95%CI 1.24-4.67)。
- 超声愈合与住院或手术风险无显著独立关联。
核心结论
- 在临床缓解期克罗恩病患者中,超声愈合与临床结局改善相关。
- 需进一步研究确定超声愈合是否应作为治疗目标。
研究设计与样本
- 回顾性研究,纳入2017年8月至2020年6月期间接受肠道超声检查且随访至少6个月的临床缓解期(HBI<4)克罗恩病患者202例(50%男性)。
主要发现
- 基线时61%的患者存在超声炎症。
- 中位随访19个月(IQR 13-27),52%患者发生药物升级,23%使用激素,21%住院,13%接受克罗恩病相关手术。
- 超声愈合与药物升级风险降低显著相关(p=0.0018),与激素使用风险降低显著相关(p=0.0247),与住院风险降低显著相关(p=0.0102),与手术风险降低相关(p=0.083)。
- 多变量分析显示,超声愈合与无药物升级生存率升高显著相关(HR 1.94,95%CI 1.23-3.06,p=0.004),与无激素生存率升高显著相关(HR 2.41,95%CI 1.24-4.67,p=0.009),但与住院或手术无显著关联。
关键数值与推荐
- 超声愈合定义为肠壁厚度≤3 mm,且彩色多普勒无充血、无炎性脂肪、无肠壁分层破坏。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Transmural healing has emerged as a treatment target in Crohn's disease (CD). We investigated whether transmural healing assessed with intestinal ultrasound (IUS) is associated with improved clinical outcomes in patients with CD in clinical remission. METHODS: Patients with CD in clinical remission at baseline (HBI <4) having IUS between August 2017 and June 2020 with at least 6-months' follow-up were retrospectively studied. Time to medication escalation, corticosteroid use and CD-related hospitalisation or surgery were compared by the presence or absence of sonographic healing, defined as bowel wall thickness ≤3 mm without hyperemia on color Doppler, inflammatory fat, or disrupted bowel wall stratification. Factors associated with survival were analyzed by Kaplan-Meier analysis using Cox proportional-hazard model. RESULTS: Of 202 consecutive patients (50% male), sonographic inflammation was present in 61%. During median follow-up of 19 (IQR 13-27) months, medication escalation occurred in 52%, corticosteroid use in 23%, hospitalisation in 21%, and CD-related surgery in 13%. Sonographic healing was significantly associated with a reduced risk of medication escalation (p = 0.0018), corticosteroid use (p = 0.0247), hospitalisation (p = 0.0102), and surgery (p = 0.083). On multivariable analysis, sonographic healing was significantly associated with an increased odds of medication escalation-free survival (hazard ratio [HR]:1.94; 95% CI 1.23-3.06; p = 0.004) and corticosteroid-free survival (HR:2.41; 95% CI 1.24-4.67; p = 0.009), but not with hospitalisation or surgery. CONCLUSION: In patients with CD in clinical remission, sonographic healing is associated with improved clinical outcomes. Further studies are needed to determine whether sonographic healing should be a treatment target.
引用
- Vaughan R, Tjandra D, Patwardhan A, et al. Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn's disease. Aliment Pharmacol Ther. 2022. PMID: 35343603. doi:10.1111/apt.16892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。